Italian Hospitals Facing Crisis: 32,500 Beds Cut and Over 11,000 Doctors Leaving In a concerning report released …
clinical
-
-
Telethon Foundation applauds the FDA’s approval of the drug against Duchenne muscular dystrophy in the USA. It …
-
Health
Perrone (Aiom), oncology cornerstone of the NHS but structural measures are urgently needed – Focus Tumor news
by admin“It is important that no citizen with a cancer is left behind, from prevention to access to …
-
Health
Virgen de la Victoria University Clinical Hospital Enhances Nuclear Medicine Services with New SPECT/TC Machine
by adminTitle: Virgen de la Victoria University Clinical Hospital Enhances Nuclear Medicine Services with New SPECT/CT Equipment Date: …
-
Business
Simcere Pharmaceutical Co., Ltd.’s new crown specific drug completed the enrollment of all patients in the third phase of clinical trials-Enterprise-中工网
by adminOriginal title: Simcere Pharmaceutical Co., Ltd.’s new crown specific drug completed the phase III clinical trial and …
-
Business
Junshi’s research on new crown oral drugs has raised questions about the primary and secondary endpoints and the truth of the single-blind design_Clinical_Research_Subjects
by adminOriginal title: Junshi’s research on new crown oral drugs has raised questions about the primary and secondary …
-
Business
Junshi Bio’s new crown oral drug phase III clinical trial reaches the primary endpoint and will communicate and submit the listing application jqknews
by adminMay 24,Junshi BiologyreleaseannouncementAccording to the statement, the oral nucleoside anti-SARSCoV-2 drug VV116 tablets (referred to as “VV116”) …
-
(ANSA) – ROME, MAY 13 – The simple prescription of an anti-inflammatory drug (for example a cortisone) …
-
Business
Hanyu Pharmaceutical: The New Crown Detection Kit Project Obtained the Ethical Review Approval of Shanghai Public Health Clinical Center_Oriental Fortune Network
by adminSummary [Hanyu Pharmaceutical: New Crown Detection Kit Project Obtained Ethical Review Approval from Shanghai Public Health Clinical …
-
Business
Kintor Pharmaceuticals Announces Phase III Clinical Results of New Crown Oral Drugs, Shares Up 106.37%_Drug_Virus_Antibody
by adminOriginal title: Kintor Pharmaceuticals announced the clinical results of the new crown oral drug Phase III, the …